Frontiers in Cardiovascular Medicine
MARCH 3, 2025
IntroductionSystemic inflammation is recognised as a critical driver of atherosclerotic cardiovascular disease (ASCVD), especially in patients with comorbid chronic kidney disease (CKD).
DAIC
JUNE 28, 2024
milla1cf Fri, 06/28/2024 - 19:07 June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa , its flagship health equity initiative, to target a broader range of non-communicable diseases (NCDs), including chronic kidney disease (CKD) as well as hypertension and cardiovascular disease.
Hypertension Journal
SEPTEMBER 14, 2023
BACKGROUND:Hypertension frequently accompanies chronic kidney disease (CKD) as etiology and sequela. Between 2011 and 2014, the age-adjusted proportion of adults with controlled BP declined from 78.0% Hypertension, Volume 80, Issue 12 , Page 2533-2543, December 1, 2023. in 2015, and then increased to 72.9%
Stroke Journal
OCTOBER 10, 2023
BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. Whether dialysis modality is associated with cerebrovascular disease is unclear. Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023. women) and 11 427 patients undergoing hemodialysis (mean age 59±13 years; 47.3%
Frontiers in Cardiovascular Medicine
OCTOBER 9, 2024
Additionally, restricted cubic splines (RCS) analysis was also employed.ResultsWe found that those with AAC were significantly older and had a higher prevalence of smoking and chronic kidney disease (CKD) prevalence compared to those without AAC.
Open Heart
APRIL 24, 2024
Results Data were collected in April 2012 to January 2014 and in June 2021 to December 2022. Frailty, chronic kidney disease and ischaemic heart disease increased significantly versus the first period (p<0.001). Statistical significance is determined at p<0.05. and 29.2%, p<0.001).
Open Heart
OCTOBER 11, 2022
Data from 36 970 consecutive PCI cases performed between 2014 and 2018 were analysed. Those who developed renal impairment were more comorbid, with higher rates of diabetes (22% vs 38% vs 38%, p<0.001), peripheral vascular disease (3.4% vs 11%, p<0.001), chronic kidney disease (19% vs 49.7%
Expert insights. Personalized for you.
52 
Let's personalize your content